BlueAsh

Life_Science_header_1 


Blue Ash Life Sciences Collaborative

Hilton Garden Inn - Blue Ash
Friday, November 13, 2009
7:30 a.m. - 10:30 a.m.

The Path to Commercialization Symposium

There has never been a more important time for us to acknowledge the impact of life science organizations in the Cincinnati USA area. The November symposium highlighted a few of the many important discoveries and inventions taking place in our region.

It was a morning of networking and interactive discussion with life science experts. They shared best practices they have executed to meet and surpass benchmarks required for innovative treatments and devices to move successfully toward commercialization.

Agenda

7:30 a.m.       Registration and Breakfast

8:00 a.m.       Presentation - Path to Commercialization: New Rules of the Road

                      Mark Collar, former Global President Procter & Gamble's Pharmaceuticals and Personal
                      Health Division will outline what it will take in the emerging era to develop and grow
                      successful life science companies                 

9:00 a.m.      Panel Discussion - Attendees learned from the experiences of these life science experts
                      who have products or treatments in various stages of the commercialization process:

                      Ken Phelps, President, Camargo Pharmaceutical - Moderator
                      View Power Point Presentation

                      Doug Ladd, Director of Market Development, Franchise Development Ethicon Endo-Surgery
                      View Power Point Presentation

                     Tom Jennings, General Counsel and Chief Regulatory Officer Xanodyne Pharmaceutical
                     View Power Point Presentation

                     Ellen Banks, JD Intellectual Property, Technology Transfer and Commercialization Licensing
                     Associate, University of Cincinnati
                     View Power Point Presentation 

                    Greg Flexter , President, Blue Ash Therapeutics
                    View Power Point Presentation

The event ended with networking and mingling amoung the over 130 attendees.

Life_Science_footer_1